The Food and Drug Administration said it has approved Talon Therapeutics Inc's Marqibo treatment for adults with a rare form of leukemia known as Philadelphia chromosome negative acute lymphoblastic leukemia
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment